IISc & Brunel University eye long-term research & educational collaboration to strengthen scientific expertise
The Indian Institute of Science (IISc), Bengaluru and the Brunel University, London are looking for long-term research and educational collaboration to strengthen scientific expertise in the country. In this regard, a £100,000 (Rs 1 crore) programme for joint research projects has been launched as part of the UK–India university collaboration.
The funding will support a number of short, exploratory joint ‘seed’ research projects running until the end of July 2023, with the expectation of later progression to larger, externally funded collaborative research.
The collaboration programme between Brunel University and IISc came about during a visit by Brunel’s Vice-Chancellor and President Professor Andrew Jones to IISc’s campus in Bengaluru. It is in support of the university’s aim to build a long-term research and educational collaboration.
Professor Jones and other senior administrators from Brunel visited IISc and interacted with faculty members, and a signed certificate was exchanged between the two institutions to mark the programme’s launch.
“Over the past couple of years, academics from our universities have been working to develop an understanding of our joint research capabilities of internationally excellent research for Brunel and for IISc,” said Professor Jones.
Professor Govindan Rangarajan, director, IISc, said: “We are gratified by the collaborations we’ve had with Brunel over the past couple of years through various joint workshops, webinars and research projects/exchanges. The launch of the Brunel–IISc International Collaboration Programme will add value to the ongoing interactions and strengthen our relationship further.”
We anticipate the extension of this cooperation to other interdisciplinary areas, where we look forward to working together and solving problems with global impact, added Professor Rangarajan.
In sync with this collaboration programme, the Union government in its Budget 2023 supported research and innovation for pharma. The impetus for public-private collaborations showcases the government’s emphasis on providing faster solutions to India’s health challenges. The government will also allow utilisation of select ICMR labs, to encourage collaborative research with the private sector R&D teams, will help bridge infrastructure gaps in the research eco-system. The focus on pharma R&D and innovation with research-oriented incentives and policies can enable the Indian pharma industry to become the R&D, bio-innovation and bio-manufacturing hub of the world. With this, the country will be in a position to meet the large healthcare demands of the masses face any future challenges.
Source : 1
AuroBlog | Clinical Research Blog | Aurous HealthCare CRO, India 